Handok Inc
KRX:002390

Watchlist Manager
Handok Inc Logo
Handok Inc
KRX:002390
Watchlist
Price: 11 190 KRW 2.47% Market Closed
Market Cap: ₩154B

Operating Margin

-0.8%
Current
Declining
by 2.7%
vs 3-y average of 1.9%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-0.8%
=
Operating Income
₩-4.2B
/
Revenue
₩516.4B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-0.8%
=
Operating Income
₩-4.2B
/
Revenue
₩516.4B

Peer Comparison

Country Company Market Cap Operating
Margin
KR
Handok Inc
KRX:002390
145.4B KRW
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
530.8B USD
Loading...
CH
Roche Holding AG
SIX:ROG
281.3B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
213.4B GBP
Loading...
CH
Novartis AG
SIX:NOVN
223B CHF
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.8T DKK
Loading...
US
Merck & Co Inc
NYSE:MRK
267.6B USD
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
147.1B USD
Loading...
FR
Sanofi SA
PAR:SAN
96.5B EUR
Loading...

Market Distribution

In line with most companies in Korea
Percentile
33rd
Based on 2 615 companies
33rd percentile
-0.8%
Low
-163 055.6% — -2.2%
Typical Range
-2.2% — 6.8%
High
6.8% — 22 874.8%
Distribution Statistics
Korea
Min -163 055.6%
30th Percentile -2.2%
Median 2.7%
70th Percentile 6.8%
Max 22 874.8%

Handok Inc
Glance View

Market Cap
154B KRW
Industry
Pharmaceuticals

Handok, Inc. engages in the manufacture and sale of pharmaceutical products. The company is headquartered in Seoul, Seoul. The firm's products include Amaryl for diabetes; Tritace for hypertension, myocardial infarction, heart failure and other cardiovascular diseases; Teveten and Triapin for essential hypertension; Munobal for hypertension and stenocardia; Ketas for disturbance of cerebral circulation; Lasix for hypertension and edema, and remedies for skin and others. The company also provides over-the-counter (OTC) pharmaceuticals, healthcare products, as well as medical devices, diagnostic reagents and vaccines. In addition, the Company is involved in the real estates rental business. On July 26, 2013, it changed its name to HANDOK Inc. from Handok Pharmaceuticals Co., LTD.

Handok Inc Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-0.8%
=
Operating Income
₩-4.2B
/
Revenue
₩516.4B
What is Handok Inc's current Operating Margin?

The current Operating Margin for Handok Inc is -0.8%, which is below its 3-year median of 1.9%.

How has Operating Margin changed over time?

Over the last 3 years, Handok Inc’s Operating Margin has decreased from 5.1% to -0.8%. During this period, it reached a low of -1.5% on Jun 30, 2025 and a high of 5.2% on Dec 31, 2022.

Back to Top